Literature DB >> 33011264

Effects of WSG, a polysaccharide from Ganoderma lucidum, on suppressing cell growth and mobility of lung cancer.

Wei-Hung Hsu1, Wei-Lun Qiu2, Shu-Ming Tsao3, Ai-Jung Tseng2, Mei-Kuang Lu4, Wei-Jyun Hua5, Hsin-Chung Cheng6, Hsien-Yeh Hsu7, Tung-Yi Lin8.   

Abstract

WSG is a water soluble polysaccharides isolated from Ganoderma lucidum. In this study, we showed that WSG, a glucose-rich polysaccharide with an average molecular mass of approximately 1000 kDa, effectively inhibited cell viability and mobility of lung cancer cells. Functional studies revealed that WSG reduced phosphorylation of ERK1/2 in cells upon either EGF or TGFβ stimulation. WSG also inhibited phosphorylation of multiple intracellular signaling molecules such as FAK, AKT and Smad2. Mechanistically, we demonstrated that WSG induced degradation of TGFβ and EGF receptors via proteasome and lysosome, respectively. Moreover, we found that WSG significantly suppressed lung tumor growth, reduced the size of metastatic nodules in the lungs and prolonged the survival of LLC1-bearing mice. Our findings suggested that WSG may have potential as a therapeutic intervention for treatment of lung cancer.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Degradation; EGFR; Ganoderma lucidum; Lung cancer; Polysaccharides; TGFβR

Mesh:

Substances:

Year:  2020        PMID: 33011264     DOI: 10.1016/j.ijbiomac.2020.09.227

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

Review 1.  Research Progress on the Anticancer Activities and Mechanisms of Polysaccharides From Ganoderma.

Authors:  Man Wang; Fei Yu
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

2.  WSG, a Glucose-Rich Polysaccharide from Ganoderma lucidum, Combined with Cisplatin Potentiates Inhibition of Lung Cancer In Vitro and In Vivo.

Authors:  Wei-Lun Qiu; Wei-Hung Hsu; Shu-Ming Tsao; Ai-Jung Tseng; Zhi-Hu Lin; Wei-Jyun Hua; Hsin Yeh; Tzu-En Lin; Chien-Chang Chen; Li-Sheng Chen; Tung-Yi Lin
Journal:  Polymers (Basel)       Date:  2021-12-13       Impact factor: 4.329

3.  Ganoderma formosanum Exopolysaccharides Inhibit Tumor Growth via Immunomodulation.

Authors:  Hsing-Chun Kuo; Yen-Wenn Liu; Chi-Chin Lum; Kai-Di Hsu; Shin-Ping Lin; Chang-Wei Hsieh; Hui-Wen Lin; Tze-Ying Lu; Kuan-Chen Cheng
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

Review 4.  Current Advancements in Antitumor Properties and Mechanisms of Medicinal Components in Edible Mushrooms.

Authors:  Jing Xu; Rui Shen; Zhuoya Jiao; Weidong Chen; Daiyin Peng; Lei Wang; Nianjun Yu; Can Peng; Biao Cai; Hang Song; Fengyuan Chen; Bin Liu
Journal:  Nutrients       Date:  2022-06-24       Impact factor: 6.706

5.  Comparative Mitogenomic Analysis Reveals Intraspecific, Interspecific Variations and Genetic Diversity of Medical Fungus Ganoderma.

Authors:  Qiang Li; Ting Zhang; Lijiao Li; Zhijie Bao; Wenying Tu; Peng Xiang; Qian Wu; Ping Li; Mei Cao; Wenli Huang
Journal:  J Fungi (Basel)       Date:  2022-07-26

Review 6.  Effects of Medicinal Fungi-Derived β-Glucan on Tumor Progression.

Authors:  Vaclav Vetvicka; Tamara V Teplyakova; Alexandra B Shintyapina; Tatiana A Korolenko
Journal:  J Fungi (Basel)       Date:  2021-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.